[Topical treatment of anal eczema].
Schauber
J
J
Klinik für Dermatologie und Allergologie, Ludwig-Maximilians-Universität, München. juergen.schauber@med.uni-muenchen.de
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D001252:Astringents / Q000008:administration & dosage; D001623:Betamethasone / Q000008:administration & dosage; D065095:Calcineurin Inhibitors; D003131:Combined Modality Therapy; D003879:Dermatologic Agents / Q000008:administration & dosage; D003937:Diagnosis, Differential; D004485:Eczema / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage; D011349:Proctitis / Q000188:drug therapy* / Q000209:etiology; D015034:Zinc Oxide / Q000008:administration & dosage
D000893:Anti-Inflammatory Agents; D001252:Astringents; D065095:Calcineurin Inhibitors; D003879:Dermatologic Agents; D001623:Betamethasone; D015034:Zinc Oxide; D006854:Hydrocortisone